Magenta Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MGTA and buy or sell other stocks, ETFs, and their options commission-free!

About MGTA

Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. 

CEO
Marino Garcia, MBA
CEOMarino Garcia, MBA
Employees
78
Employees78
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2015
Founded2015
Employees
78
Employees78

MGTA Key Statistics

Market cap
385.19M
Market cap385.19M
Price-Earnings ratio
-7.05
Price-Earnings ratio-7.05
Dividend yield
—
Dividend yield—
Average volume
411.92K
Average volume411.92K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$32.27
52 Week high$32.27
52 Week low
$13.37
52 Week low$13.37

People also own

Based on the portfolios of people who own MGTA. This list is generated using Robinhood data, and it’s not a recommendation.
Ocugen, Inc
Plug Power
Tilray Brands
Inovio
Aurora Cannabis
Virgin Galactic Holdings
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.